Woodline Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Sell |
724,910
-319,700
| -31% | -$5.36M | 0.06% | 382 |
|
|
2025
Q1 | $16.1M | Hold |
1,044,610
| – | – | 0.1% | 264 |
|
|
2024
Q4 | $23M | Sell |
1,044,610
-2,943
| -0.3% | -$64.9K | 0.16% | 187 |
|
|
2024
Q3 | $18.9M | Hold |
1,047,553
| – | – | 0.16% | 198 |
|
|
2024
Q2 | $17M | Hold |
1,047,553
| – | – | 0.16% | 182 |
|
|
2024
Q1 | $14.8M | Hold |
1,047,553
| – | – | 0.14% | 208 |
|
|
2023
Q4 | $10.9M | Buy |
+1,047,553
| New | +$10.9M | 0.12% | 220 |
|
|
2022
Q3 | – | Sell |
-2,040,175
| Closed | -$15.3M | – | 816 |
|
|
2022
Q2 | $15.3M | Buy |
+2,040,175
| New | +$15.3M | 0.24% | 131 |
|